MARK PHILLIPS: Open Payments
NPI 1336633106 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 84 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $423 |
| PFIZER INC. | 18 | $235 |
| Collegium Pharmaceutical, Inc. | 11 | $182 |
| Novo Nordisk Inc | 10 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Astellas Pharma US Inc | 2 | $43 |
| Lilly USA, LLC | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Edwards Lifesciences Corporation | 1 | $16 |
Products named: NURTEC ODT, UBRELVY, Belbuca, QULIPTA, Wegovy, VRAYLAR, TRINTELLIX, Veozah.
Industry payments across NC — which companies pay providers there.
